S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

RNAC Cartesian Therapeutics Inc

19.79

-0.09 (-0.45%)

Dec 27 2024 - Closed

Delayed by 15 minutes

Form 424B7 - Prospectus [Rule 424(b)(7)]

Article too big to display. Click here to view on the SEC website

Cartesian Therapeutics (NASDAQ:RNAC)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Cartesian Therapeutics Charts.

Cartesian Therapeutics (NASDAQ:RNAC)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Cartesian Therapeutics Charts.

Cartesian Therapeutics Inc News

Cartesian Therapeutics Announces New Employment Inducement Grants
Wednesday 18 December 2024 (1 week ago) • GlobeNewswire Inc.

Form S-3 - Registration statement under Securities Act of 1933
Friday 13 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Friday 13 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Friday 13 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 11 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 10 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Monday 9 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 3 December 2024 (4 weeks ago) • Edgar (US Regulatory)

Cartesian Therapeutics Announces Positive Updated Results from Phase 2b Trial of Descartes-08 in Participants with Myasthenia Gravis and Outlines Design of Planned Phase 3 Trial
Tuesday 3 December 2024 (4 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 21 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 21 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 21 November 2024 (1 month ago) • Edgar (US Regulatory)

More Cartesian Therapeutics Inc News Articles

Decentral Life (PK)

Bioelectronics (PK)

Good Vibrations Shoes (PK)

Rennova Health (CE)

Kraig Biocraft Laborator... (QB)

Code Green Apparel (PK)

Virexit Technologies (PK)

Northwest Biotherapeutics (QB)

Fannie Mae (QB)

Elite Pharmaceuticals (QB)

Movement Industries (PK)

North Bay Resources (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions